Two drugs are particularly affected: Ozempic (semaglutide) and Trulicity (dulaglutide). “They are indicated in the treatment of poorly controlled type 2 diabetes, in addition to diet and physical activity”, details the Agency. Despite these difficulties of access, the ANSM calls on affected patients to “not to modify (their) treatment without medical advice”. “Talk to your doctor who will prescribe an alternative if necessary.”
Tag:
medications
» Signing of a partnership agreement between Leem and ALLIS-NA MyPharma Editions
written by Alexandra Hartman Editor-in-Chief
Posted on Wednesday, September 14, 2022
In order to strengthen links with regional health players and promote the sector in the region, Leem (Les Entreprises du Médicament) and the Alliance Innovation Santé Nouvelle-Aquitaine (ALLIS-NA), a regional skills center for players from the health sector, have just signed a partnership agreement in the presence of Philippe Lamoureux, general manager of Leem, and Christian Fillatreau, president of ALLIS-NA.
With more than 6,000 employees and numerous developments, particularly in terms of bioproduction, Nouvelle-Aquitaine is a strategic region for the pharmaceutical industry.
For Phillipe Lamoureux, “signing this agreement will give more visibility to the sector, promote its attractiveness in the region and work together on the important issues for the region’s industrialists. We reinforce our desire for greater proximity, as close as possible to the territories and projects of our companies. We are happy to have signed this agreement with ALLIS-NA, which structures and leads the health sector in New Aquitaine. »
For Christian Fillatreau, “the agreement linking Leem and ALLIS NA embodies the existence of convergence in their respective strategic orientations, both territorially and thematically. With regard to New Aquitaine, ALLIS-NA is a natural partner with regard to the choice of a territorial rooting which has been its since its creation. This rapprochement with the living forces of the health ecosystem of the New Aquitaine Region is a common objective likely to generate reflections, actions, common events.
ALLIS-NA invests in the broad field of health innovations in their great thematic diversity; this makes it possible to highlight the apparent porosity and transversality of the different fields of health innovation between drugs, medical devices, telemedicine, patient pathways and follow-up, without forgetting prevention and public health. The Leem and ALLIS-NA are intended, in this dimension specific to health innovation, to carry out synergistic actions conducive to the development of projects involving players in the health ecosystem of New Aquitaine, including in the field of organizational innovation. “.
This partnership illustrates Leem’s commitment to a policy of proximity, sharing with the territories and their health ecosystem. Leem is thus continuing to build its territorial animation, already formalized by agreements with GIMRA and AFIPRAL in Auvergne Rhône Alpes, BFCare in Bourgogne Franche Comté and GREPIC in Center Val de Loire.
Source : read
Share the post “Signing of a partnership agreement between Leem and ALLIS-NA”
Horseshoe crabs, “living fossils” essential to produce the vaccine against Covid-19
written by Alexandra Hartman Editor-in-Chief
Published on : 01/07/2022 – 18:54
Every spring, hundreds of thousands of horseshoe crabs, a species older than the dinosaurs, come to breed on the beaches of Delaware Bay, on the East Coast of the United States. Horseshoe crabs are vital in ensuring that vaccines given to humans are safe. Their blood is used by the biotechnology industry in a test that helps ensure that a vaccine, including that once morest Covid-19, is not contaminated with toxic bacteria.
Published on : 03/06/2022 – 11:43
The sanctions imposed following the invasion in Ukraine are being felt in Russia in the health sector. To obtain certain medicines, which have become impossible to find in pharmacies, the inhabitants are forced to order them in Turkey.
Finding certain drugs is a headache in Russia. In question, the Western sanctions taken once morest Moscow following the invasion of Ukraine. On a daily basis, Russian patients have to find solutions to circumvent the sanctions and continue their treatment. A report by Elena Voloshin.